Back to search
FDAFDA · Food and drugs·Recall number Z-1682-2020

McKesson Cardiology ECG Management, Change Healthcare Cardiology ECG Management

Published April 15, 2020 · Recall initiated: February 10, 2020

Summary

FDA records medical device Class II recall Z-1682-2020, published April 15, 2020 and initiated February 10, 2020. Recalling firm: CHANGE HEALTHCARE CANADA COMPANY; Status: Ongoing; Reported quantity: 51 units; Lot: McKesson Cardiology Software Versions: 13.2.1 HF1, 13.2.1 HF2, 14.0, 14.0 HF1, 14.0 HF2; Change Healthcare Software Versions: 14.1.1, 14.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Inaccurate estimation of the heart rate may occur in instances where the user is estimating heart rate counting grid squares using the Sequential ECG format

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CHANGE HEALTHCARE CANADA COMPANY
Distributor
Distribution US nationwide, Canada and the United Kingdom
Lot
McKesson Cardiology Software Versions: 13.2.1 HF1, 13.2.1 HF2, 14.0, 14.0 HF1, 14.0 HF2; Change Healthcare Software Versions: 14.1.1, 14.2
Risk classification
Class II
Area (FDA)
device
Country
Canada

Related recalls

Questions about this recall

Was McKesson Cardiology ECG Management, Change Healthcare Cardiology ECG Management recalled?

Yes. FDA published recall Z-1682-2020 on April 15, 2020. Reported hazard: Inaccurate estimation of the heart rate may occur in instances where the user is estimating heart rate counting grid squares using the Sequential ECG format

What should I do if I have this product?

Voluntary: Firm initiated · Letter